GSK hails trial of a ‘second generation’ fake ‘Covid vaccine’ to inoculate against fake variants of the fake virus. And each one will be required to keep your ‘vaccine passport’. It only ends when WE end it
Glaxosmithkline has hailed promising early trials of a ‘second generation’ Covid vaccine that could be used to inoculate patients against variants of the virus. The pharmaceutical company has been jointly developing the shots – which use cutting-edge messenger RNA (mRNA)
Read More